A dose-escalation study of docetaxel, oxaliplatin and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancer.

被引：0
|
作者：
Sato, Yasushi
Sagawa, Tamotsu
Takahashi, Yasuo
Ohnuma, Hiroyuki
Hamaguchi, Kyoko
Hirakawa, Masahiro
Fujikawa, Koshi
Okamoto, Koichi
Miyamoto, Hiroshi
Muguruma, Naoki
Takayama, Tetsuji
机构：
[1] Tokushima Univ, Grad Sch Biomed Sci, Tokushima, Japan
[2] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[3] Sapporo Med Univ, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
174
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Sato, Yasushi
    Takayama, Tetsuji
    Sagawa, Tamotsu
    Takahashi, Yasuo
    Ohnuma, Hiroyuki
    Okubo, Syunichi
    Shintani, Naoaki
    Tanaka, Shingo
    Kida, Masaya
    Sato, Yasuhiro
    Ohta, Hidetoshi
    Miyanishi, Koji
    Sato, Tsutomu
    Takimoto, Rishu
    Kobune, Masayoshi
    Yamaguchi, Koji
    Hirata, Koichi
    Niitsu, Yoshiro
    Kato, Junji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 721 - 728
  • [42] A triplet combination with capecitabine/oxaliplatin/irinotecan (XELOXIRI) plus cetuximab as first-line therapy for patients with metastatic colorectal cancer: a dose escalation study
    Sato, Yasushi
    Hirakawa, Masahiro
    Ohnuma, Hiroyuki
    Takahashi, Minoru
    Okamoto, Tetsuro
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Muguruma, Naoki
    Furuhata, Tomohisa
    Takemasa, Ichiro
    Kato, Junji
    Takayama, Tetsuji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (06) : 1133 - 1139
  • [43] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Takayama, T.
    Sato, Y.
    Sagawa, T.
    Okamoto, T.
    Nagashima, H.
    Takahashi, Y.
    Ohnuma, H.
    Kuroiwa, G.
    Miyanishi, K.
    Takimoto, R.
    Matsunaga, T.
    Kato, J.
    Yamaguchi, K.
    Hirata, K.
    Niitsu, Y.
    BRITISH JOURNAL OF CANCER, 2007, 97 (07) : 851 - 856
  • [44] Phase I/II study of docetaxel, CDDP and S-1 in unresectable advanced gastric cancer.
    Takayama, T
    Sato, Y
    Okamoto, T
    Sagawa, T
    Abe, T
    Ihara, H
    Nagashima, H
    Kato, J
    Niitsu, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 362S - 362S
  • [45] A triplet combination with capecitabine/oxaliplatin/irinotecan (XELOXIRI) plus cetuximab as first-line therapy for patients with metastatic colorectal cancer: a dose escalation study
    Yasushi Sato
    Masahiro Hirakawa
    Hiroyuki Ohnuma
    Minoru Takahashi
    Tetsuro Okamoto
    Koichi Okamoto
    Hiroshi Miyamoto
    Naoki Muguruma
    Tomohisa Furuhata
    Ichiro Takemasa
    Junji Kato
    Tetsuji Takayama
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 1133 - 1139
  • [46] Clinical Study of S-1 Plus Oxaliplatin Versus S-1 Plus Cisplatin as First-Line Treatment for Elderly Patients with Advanced Gastric Cancer
    Bo Deng-feng
    Hu Xiu-fu
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2015, 3 (04): : 238 - 242
  • [47] Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: A retrospective analysis.
    Tanabe, K.
    Suzuki, T.
    Tokumoto, N.
    Yamamoto, H.
    Yoshida, K.
    Ohdan, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] A phase II study of biweekly oxaliplatin plus S-1 combination chemotherapy as a first-line treatment for patients with metastatic or advanced gastric cancer in China
    Xiao, Cheng
    Qian, Jiong
    Zheng, Yulong
    Song, Fang
    Wang, Qiangfeng
    Jiang, Haiping
    Mao, Chenyu
    Xu, Nong
    MEDICINE, 2019, 98 (20)
  • [49] Comparison of early tumor shrinkage between oxaliplatin plus S-1 and cisplatin plus S-1 in first-line chemotherapy with advanced gastric cancer.
    Osumi, Hiroki
    Takahari, Daisuke
    Shinozaki, Eiji
    Chin, Keisho
    Ogura, Mariko
    Nakayama, Izuma
    Matsushima, Tomohiro
    Wakatsuki, Takeru
    Ichimura, Takashi
    Suenaga, Mitsukuni
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [50] Feasibility Study of Oxaliplatin with Oral S-1 or Capecitabine as First-line Therapy for Patients with Metastases from Colorectal Cancer
    Watanabe, Kazuhiro
    Kawahara, Hidejiro
    Enomoto, Hiroya
    Toyama, Yoichi
    Akiba, Tadashi
    Yanaga, Katsuhiko
    ANTICANCER RESEARCH, 2013, 33 (09) : 4029 - 4032
12345